1.
Ashutosh D. Wechalekar, Helen J. Lachmann, Mark Offer, Philip N. Hawkins, Julian D. Gillmore. Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease. Haematologica 2008; 93(2):295-298; https://doi.org/10.3324/haematol.11627.